GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38918
Submission : 2023-10-03
Status : Active
Type : IV
Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35699
Submission : 2021-04-14
Status : Active
Type : IV
Certificate Number : R0-CEP 2020-419 - Rev 00
Issue Date : 2022-04-01
Type : Chemical
Substance Number : 428
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24384
Submission : 2010-08-12
Status : Active
Type : IV
Certificate Number : R0-CEP 2000-310 - Rev 02
Issue Date : 2005-03-16
Type : TSE
Substance Number : 428
Status : Withdrawn by Holder

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24398
Submission : 2010-09-09
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26300
Submission : 2012-07-24
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35475
Submission : 2020-12-21
Status : Inactive
Type : IV
Certificate Number : R0-CEP 2020-048 - Rev 00
Issue Date : 2020-09-04
Type : Chemical
Substance Number : 428
Status : Withdrawn by Holder

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38918
Submission : 2023-10-03
Status : Active
Type : IV
Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35699
Submission : 2021-04-14
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35475
Submission : 2020-12-21
Status : Inactive
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26300
Submission : 2012-07-24
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24398
Submission : 2010-09-09
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24384
Submission : 2010-08-12
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FINISHED DOSAGE FORMULATIONS
Drug : PRIMAQUINE
Dosage Form : TABLET; ORAL
Application Number : 8316
Country : US
Patented : No
Drug : CABLIVI
Dosage Form : INJECTABLE; INJECTION
Application Number : 761112
Country : US
Patented : No
Drug : MYOZYME
Dosage Form : INJECTABLE; IV (INFUSION)
Application Number : 125141
Country : US
Patented : No
Drug : TAXOTERE
Dosage Form : INJECTABLE; INJECTION
Application Number : 20449
Country : US
Patented : No
NEBIVOLOL HYDROCHLORIDE; VALSARTAN
Drug : BYVALSON
Dosage Form : TABLET; ORAL
Application Number : 206302
Country : US
Patented : Yes
Drug : FML
Dosage Form : SUSPENSION/DROPS; OPHTHALMIC
Application Number : 16851
Country : US
Patented : No
LEUPROLIDE ACETATE; NORETHINDRONE ACETATE
Drug : LUPANETA PACK
Dosage Form : INJECTABLE, TABLET; INTRAMUSCULAR, ORAL
Application Number : 203696
Country : US
Patented : No
Drug : GENGRAF
Dosage Form : CAPSULE; ORAL
Application Number : 65003
Country : US
Patented : No
Drug : NORVIR
Dosage Form : TABLET; ORAL
Application Number : 22417
Country : US
Patented : No
Drug : KALETRA
Dosage Form : TABLET; ORAL
Application Number : 21906
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
11 Oct 2025
Reply
29 Apr 2025
Reply
27 Dec 2024
Reply
24 Sep 2024
Reply
21 Sep 2024
Reply
25 Jul 2023
Reply
07 Nov 2022
Reply
27 Sep 2022
Reply
09 Sep 2022
Reply
09 Aug 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES